![Peter Bantock](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Peter Bantock
Former positions of Peter Bantock
Companies | Position | Start | End |
---|---|---|---|
Ventana Medical Systems, Inc.
![]() Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 31/12/2010 | 30/09/2012 |
ACCELERATE DIAGNOSTICS, INC. | Human Resources Officer | 31/03/2015 | - |
Corporate Officer/Principal | - | - |
Training of Peter Bantock
Rhodes University | Undergraduate Degree |
Statistics
International
United States | 3 |
South Africa | 2 |
Operational
Corporate Officer/Principal | 2 |
Human Resources Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ACCELERATE DIAGNOSTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Ventana Medical Systems, Inc.
![]() Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
- Stock Market
- Insiders
- Peter Bantock
- Experience